Blue dye for identification of sentinel nodes in breast cancer and malignant melanoma: a systematic review and meta-analysis

Future Oncol. 2017 Feb;13(5):455-467. doi: 10.2217/fon-2016-0255. Epub 2016 Aug 31.

Abstract

The combined technique (radioisotope and blue dye) is the gold standard for sentinel lymph node biopsy (SLNB) and there is wide variation in techniques and blue dyes used. We performed a systematic review and meta-analysis to assess the need for radioisotope and the optimal blue dye for SLNB. A total of 21 studies were included. The SLNB identification rates are high with all the commonly used blue dyes. Furthermore, methylene blue is superior to iso-sulfan blue and Patent Blue V with respect to false-negative rates. The combined technique remains the most accurate and effective technique for SLNB. In order to standardize the SLNB technique, comparative trials to determine the most effective blue dye and national guidelines are required.

Keywords: Patent Blue V; SLNB; blue dye; breast; combined technique; iso-sulfan blue; malignant melanoma; methylene blue; radioisotope; sentinel lymph node biopsy.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Coloring Agents*
  • Female
  • Humans
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis
  • Melanoma / diagnosis*
  • Neoplasm Recurrence, Local
  • Sensitivity and Specificity
  • Sentinel Lymph Node Biopsy* / adverse effects
  • Sentinel Lymph Node Biopsy* / methods

Substances

  • Coloring Agents